Language
Inter-Pharma – pharmaceutical solutions in Europe

News topic

Active ingredient Eribulin

Current shortage notices for the active ingredient Eribulin, structured by product, country and reporting period.

2 notices

← All shortages

Belgium

Eribulin Baxter 0.44 mg/ml inj. sol. i.v. vial 2 ml

Active ingredient: Eribulin

View notice details →
Belgium

Eribulin Baxter 0.44 mg/ml inj. opl. i.v. flac. 2 ml

Active ingredient: Eribulin

View notice details →